EP1400258A1 — Pharmaceutical composition delivery device and its manufacturing process
Assigned to Bayer Oy · Expires 2004-03-24 · 22y expired
What this patent protects
The invention relates to a delivery system comprising a body construction (7) and at least one capsule (8) containing a pharmaceutical composition, said capsule having at least a first end and a second end. According to the invention the body construction (7) has at least two loc…
USPTO Abstract
The invention relates to a delivery system comprising a body construction (7) and at least one capsule (8) containing a pharmaceutical composition, said capsule having at least a first end and a second end. According to the invention the body construction (7) has at least two locking parts (9, 10), each locking part having a surface adapted to face and cover one of the at least first and second ends of the capsule (8), and in that the capsule (8) is mounted between said at least two locking parts (9, 10). The invention further relates to one manufacturing process of a delivery system, said system comprising a body construction and at least one capsule containing a pharmaceutical composition.
Drugs covered by this patent
- Jadelle (LEVONORGESTREL) · Fdn Consumer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.